Rx Item-Narcan naloxone Nasal 4Mg Spray 2X0.1 Ml By Adapt Pharma
Comparative Human Factors Evaluation of Two Nasal Naloxone Administration Devices: NARCAN® Nasal Spray and Naloxone Prefilled Syringe with Nasal Atomizer | Pain and Therapy
Over-the-counter Narcan hitting shelves in September | Pittsburgh Post-Gazette
Bodycam shows first responders using Narcan to save man's life after he swallowed heroin
Patent Docs: Adapt Pharma Operations Ltd. v. Teva Pharmaceuticals USA, Inc. (Fed. Cir. 2022)
Adapt v13_bios
208411Orig1s000
Narcan to be made available throughout Spirit Lake, IA school buildings
Crise nationale des opioïdes : le Canada approuve la distribution sans ordonnance du vaporisateur qui redonne vie – RCI | Français
Adapt Pharma
DOJ Global Normal Template
Adapt Pharma Release: NARCAN (Naloxone Hcl) Nasal Spray 2mg Approved By FDA | BioSpace
Adapt Pharma - Crunchbase Company Profile & Funding
Veterans Affairs & Military Medicine Outlook 2016 by Faircount Media Group - Issuu
Applied Pharmaceutical Distribution Inc.
Emergent BioSolutions Acquires Adapt Pharma in $735 Million Deal | BioSpace
Emergent BioSolutions Inc. jumps into opioid crisis with latest acquisition of Adapt Pharma Inc. - Washington Business Journal